drugset / Trial / NCT00692510

Drug Interaction Study Between AZD3480 and Cytochrome P450

NCT00692510

Phase 1 Completed 18 enrolled AstraZeneca
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of the study is to evaluate if AZD3480 inhibits Cytochrome P450 1A2, 2C19, 3A4, 2C8, 2B6 and UGT1A1 activity.

Timeline

Start
2007-11
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject ispronicline Small molecule Oral
Background Bilirubin Small molecule
Background Bupropion Small molecule
Background Caffeine Small molecule
Background Midazolam Small molecule
Background Omeprazole Other / unclassified
Background Rosiglitazone Small molecule

Indications